Introduction
Stroke is a major risk factor for the development of epilepsy, especially in the elderly [1] . The incidence of seizures was found to be 10.6% in 265 patients with intracerebral hemorrhage and 8.6% among 1,632 patients with ischemic stroke [2] . Several seizure predictors have been studied including: stroke subtype, size, location, severity of the vascular lesion, and the presence of previous seizures [3] [4] [5] . However, there is little data available regarding both early warning signs and preventative therapies for post-stroke epilepsy (PSE).
Based on the time of onset following the initial cerebral ischemic event, seizures are traditionally divided into two types: early and late [2] . In general, the former refers to the onset of seizures within 2 weeks after stroke, and the latter refers to the onset of seizures after 2 weeks following stroke [6] [7] [8] . In stroke patients, 35% of patients with early onset seizures and 90% with late onset seizures developed epilepsy [9] . In most patients with early-onset seizures, the seizures began within 1-2 days after the infarction [10] .
The pathophysiology of epilepsy after stroke These changes have been documented in the penumbral areas in the acute post-stroke phase [11] [12] [13] . In addition, the accumulation of intracellular calcium and sodium results in depolarization of the transmembrane potential, and this, taken together with other calcium-mediated effects, can lower the seizure threshold [2] . Based on these aspects of amino acid neurotransmitters and ion levels, we performed an intervention study.
In this study, we aimed to identify early predictors of PSE by measuring changes in blood levels of GABA, Glu, and calcium (Ca 2 + ) in order to develop preventative therapeutic strategies for PSE.
Methods
The study was performed with the approval of the ethics committee of the First hospital The purpose of this study was to identify predictors and preventative treatments for post-stroke epilepsy (PSE). Methodology: Eighty-four patients who had suffered a cerebrovascular insult (within 72 hours) were recruited and divided into two groups: an EP group (patients with seizures after stroke) and a NEP group (patients without seizures after stroke). The NEP group was then subdivided into three groups: a control group, a GABA (γ-aminobutiric acid) group (received GABA orally), and a CCB group (received calcium channel blocker nimodipine orally). Patient groups were compared by gender, age, past medical history, stroke type, number of lesions, and position and stroke severity (using Scandinavian stroke scale, SSS). Forearm venous blood was sampled, and high performance liquid chromatography (HPLC) was used to measure plasma levels of neurotransmitters and Ca
2+
. Patients then received 14 days of drug intervention. One month after drug withdrawal, GABA, glutamate (Glu) and Ca 2+ concentrations in plasma were measured again. Results: The number of previous strokes, size of infarction, presence of multiple lesions, localization to the cortex, and SSS were statistically significant between the two groups (P < 0.05). In the EP group, the Glu concentration was greater and the Ca 2+ concentration was lower than in the NEP group (P < 0.05). The results obtained after 1 month of therapy showed a reduction in Glu levels and an increase in GABA levels in the GABA group relative to the control NEP group (P < 0.05), while the CCB group showed a decrease in the concentration of Glu and an increase in the concentrations of GABA and Ca 2+ relative to the NEP control group (P < 0.05). Conclusions: We identified susceptibility factors for PSE and demonstrated that GABA and calcium antagonists may have a therapeutic use in the early prevention of PSE. After taking GABA and nimodipine, three patients had dry stool, four had transient dizziness, and two had nausea. Adverse reactions were mild, with the longest duration being 3 days.
There was no significant difference in sex ratio or average age between the EP and NEP groups. In the EP group, the incidence of previous stroke history was significantly greater than in the other group (P < 0.05). Constituent ratio of the infarction in the EP group was significantly higher than the NEP group (P < 0.05). Relative to the NEP group, a greater proportion of patients in the EP group had multiple lesions (P < 0.05), and these lesions were more likely to be localized in the cortex (P < 0.001). We also found that the more severe the stroke (SSS < 30), the greater the number of seizures the patients had (P < 0.05) (data summarized in Table 1 ).
When we compared EP group to NEP group, we found that Glu concentration increased, Table 1 . General characteristics of the patient population (n = 84). EP, epilepsy after stroke; NEP, no epilepsy after stroke; *Scandinavian stroke scale. Table 2 ).
discussion
In this study, we evaluated the reliability of previously proposed predictors of seizures following stroke. We found that ischemic stroke, cortical location, and a severe stroke score (SSS < 30) were possible predictors for seizure development.
The age of the patients ranged from 45 to 79 years old in the EP group, and we found no evidence that age is a significant predictor for PSE. This is consistent with a report by Paolucci et al. [14] who found that the risk of seizures in younger patients relative to older ones was small and not statistically significant [5] .
Previous studies have shown that the number of lesions, their location, and severity are risk factors for the development of PSE [7, 10, [15] [16] [17] . Multivariate analysis of data from seizures occurring after stroke identified a cortical location as a significant risk factor [2] .
In addition, both population-based [7] and prospective multicenter studies [2] reported that stroke severity was independently linked with the development of seizures after ischemic stroke [4] . Indeed, it was found that severe strokes, defined as SSS score < 30 at hospital admission, were a significant predictor for the development of PSE [5] .
Unlike previous studies [2, 15, 18, 19] , we did not determine if hemorrhagic stroke was a significant predictor of seizures. There is an association between intracerebral hemorrhage and early seizures, especially for subarachnoid hemorrhage [20] [21] [22] . The mechanism of hemorrhage induced seizure initiation remains unclear. Hemosiderin, a
product of blood metabolism, may cause focal cerebral irritation by promoting iron deposition in the cerebral cortex leading to seizures [23] . Perhaps the sequestration of hemosiderin in cortical neurons plays a role in seizures following traumatic brain injury as well [24] . In this study, we only evaluated whether ischemic stroke was a significant predictor for PSE. Given the small sample size, short follow-up period, and economic limitations, the role of subarachnoid hemorrhage was not examined.
Statins are commonly used to lower cholesterol levels and are considered first-line agents in the primary and secondary prevention of cardiovascular and cerebrovascular diseases.
There is mounting evidence that statins play a protective role in acute stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy [25] [26] [27] [28] . Etminan et al. reported that statins can reduce the risk of hospitalization for epilepsy in the elderly [29] , but the mechanism of action was unclear. Therefore, all patients in our study received atorvastatin (20 mg/day) in order to reduce the potential variation due to statins.
Acute ischemia leads to increased extracellular concentrations of glutamate, an excitatory neurotransmitter that has been associated with secondary neuronal injury [10, 30] . Glutamate excitotoxicity is a well- 
